Long-term Follow Up of Mesenchymal Hamartoma of Liver
Author Information
Author(s): Pandey Anand, Gangopadhyay Ajay N., Sharma Shiv P., Kumar Vijayendra, Gupta Dinesh K., Gopal Saroj C., Patne Shashikant C.
Primary Institution: Institute of Medical Sciences, Banaras Hindu University
Hypothesis
This study aims to highlight clinical features, diagnosis and treatment of mesenchymal hamartoma of the liver.
Conclusion
Mesenchymal hamartoma of the liver is a benign tumor that can be effectively treated with adequate resection and has a satisfactory long-term follow-up.
Supporting Evidence
- The study included nine patients diagnosed with mesenchymal hamartoma of the liver over 20 years.
- Surgical options included hepatic lobectomy, wedge resection, and enucleation.
- Overall mortality was 11.11%, with one patient experiencing a cardiac arrest during surgery.
Takeaway
This study looked at a rare liver tumor in kids and found that with surgery, most kids do well and don't have problems later.
Methodology
This was a retrospective study that included all patients diagnosed with mesenchymal hamartoma of the liver over a 20-year period.
Limitations
The study is limited by its small sample size and retrospective design.
Participant Demographics
The mean age of patients was 19.89 months, with a male to female ratio of 8:1.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website